Latest operating income for HOVNP: $3.1B.
Get informed when a big investor buys or sells
+ FollowAs of Jul 31, 2026
Trailing 12 months ending Jul 31, 2026
As of the most recent data (July 2026), HOVNP shows a operating income of $3.1B. That compares with $1.7B in the prior-year period — up 84.5% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, HOVNP's operating income is now $3.1B (was $1.7B) — a 84.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Hovnanian Enterprises - 7.625% PRF PERPETUAL USD 25000 - Ser A is outperforming or lagging.
Tracking HOVNP's operating income over time shows whether Hovnanian Enterprises - 7.625% PRF PERPETUAL USD 25000 - Ser A is scaling, shrinking, or reshaping that part of the business. The current reading is $3.1B That compares with $1.7B in the prior-year period — up 84.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this operating income page, Stockcircle has Hovnanian Enterprises - 7.625% PRF PERPETUAL USD 25000 - Ser A's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $3.1B) with ownership activity and broader fundamentals.
Hovnanian Enterprises - 7.625% PRF PERPETUAL USD 25000 - Ser A's operating income is $3.1B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.